The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. AIM ImmunoTech Inc shares valued at $6,730 were purchased by Equels Thomas K on Mar 05 ’25. At $0.13 per share, Equels Thomas K acquired 50,000 shares. The insider’s holdings grew to 1,858,029 shares worth approximately $0.24 million following the completion of this transaction.
Also, Equels Thomas K purchased 44,000 shares, netting a total of over 5,060 in proceeds. Following the buying of shares at $0.12 each, the insider now holds 1,808,029 shares.
Before that, Equels Thomas K had added 83,334 shares to its account. In a trade valued at $10,000, the CEO & President bought AIM ImmunoTech Inc shares for $0.12 each. Upon closing the transaction, the insider’s holdings increased to 83,334 shares, worth approximately $0.23 million.
Analyzing AIM Stock Performance
During the last five days, there has been a surge of approximately 5.00%. Over the course of the year, AIM ImmunoTech Inc shares have dropped approximately -32.17%. Shares of the company reached a 52-week high of $0.2540 on 01/07/25 and a 52-week low of $0.1105 on 02/25/25. A 50-day SMA is recorded $0.1777, while a 200-day SMA reached $0.2758.
Support And Resistance Levels for AIM ImmunoTech Inc (AIM)
According to the 24-hour chart, there is a support level at 0.1264, which, if violated, would cause prices to drop to 0.1185. In the upper region, resistance lies at 0.1396. The next price resistance is at 0.1449. RSI (Relative Strength Index) is 42.69 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.0022, which suggests the price will decrease in the coming days. Percent R is at 50.72%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
